Statistics

overview

www.mutationtypesinmnsclc.com/

Safety and Efficacy of GilotrifÂ® (afatinib) tablets established in patients whose tumors have other EGFR mutations (Del19 and L858R). While taking GILOTRIF ...

Mutationtypesinmnsclc.com

Domain is redirected to: Gilotrif.com

Conversion Technology Metas Server

Mutationtypesinmnsclc.com is hosted in Germany . Mutationtypesinmnsclc.com doesn't use HTTPS protocol. Number of used technologies: 3. First technologies: CSS, Html, Javascript, Number of used javascripts: 6. First javascripts: 1.7.1-jquery.min.js, Head.js, Client_specific_head.js, Number of used analytics tools: 1. First analytics tools: Google Analytics, Its server type is: Apache.

Technologies in use by Mutationtypesinmnsclc.com

Technology

Number of occurences: 3

CSS
Html
Javascript

Javascripts

Number of occurences: 6

1.7.1-jquery.min.js
head.js
client_specific_head.js
main.js
client_specific.js
webtrends.js

Analytics

Number of occurences: 1

Google Analytics

Server Type

Apache

Conversion rate optimization
Clickable call number	Not founded!
Conversion form (contact form, subcriber)	Not founded!
Clickable email	Not founded!
CTA (call to action) button	Not founded!
List	Founded!
Image	Not founded!
Enhancement	Not founded!
Responsive website	Founded!
Facebook sharing	Not founded!
Google+ sharing	Not founded!
Twitter sharing	Not founded!
Linkedin sharing	Not founded!
Blog on the webiste	Not founded!

HTTPS (SSL) - Mutationtypesinmnsclc.com

Missing HTTPS protocol.

Meta - Mutationtypesinmnsclc.com

Number of occurences: 10

Name:
Content: text/html; charset=utf-8
Name: language
Content: en
Name: description
Content: Safety and Efficacy of GilotrifÂ® (afatinib) tablets established in patients whose tumors have other EGFR mutations (Del19 and L858R). While taking GILOTRIF, side effects may occur. Please see important safety information and prescribing information in this website.
Name: keywords
Content:
Name: viewport
Content: width=device-width, initial-scale=1.0
Name: publisher
Content: Boehringer Ingelheim
Name: copyright
Content: Â© 1999 - 2012 Boehringer Ingelheim GmbH
Name: google-site-verification
Content: 62EvuTtReKzoCL_F4p3pWeNrMKYg2LA6FpBlLC5YeiM
Name: WT.cg_n
Content: Treatment | HCP | GilotrifÂ® (afatinib) tablets
Name: WT.cg_s
Content: GILOTRIF Overview

Server / Hosting

IP: 94.100.253.199
Latitude: 51.30
Longitude: 9.49
Country: Germany

Rname

obs.ns1.fr
ns3.nameshield.net
ns2.observatoiredesmarques.fr

Target

technical.nameshield.net

HTTP Header Response

HTTP/1.1 301 Moved Permanently Date: Thu, 30 Jun 2016 18:59:44 GMT Server: Apache Location: https://www.gilotrif.com/healthcare_professionals/gilotrif_overview/overview.html Content-Type: text/html; charset=iso-8859-1 X-Cache: MISS from s_xt27 X-Cache-Lookup: MISS from s_xt27:80 Via: 1.1 s_xt27 (squid/3.5.6) Connection: keep-alive HTTP/1.1 200 Connection established HTTP/1.1 200 OK Date: Thu, 30 Jun 2016 18:59:45 GMT Server: Apache Set-Cookie: JSESSIONID=A660CA34C97892CFEA2A8950F61BDF9C.worker1; Path=/; HttpOnly Last-Modified: Wed, 29 Jun 2016 15:08:36 GMT Accept-Ranges: bytes Pragma: no-cache Cache-Control: no-cache,no-store Set-Cookie: cq-auth=false; Version=1; Comment=com.boehringer.netvision.aggregation.engine.XmlResource; Domain=""; Path=/ node: Metis Content-Type: application/xml;charset=utf-8 Set-Cookie: Proteus=!1MQZ1tiWT9+qT2U+Dbk8KwKU9txt1iz7nXV+7KWf8oXZvfrazQUYTcH/0LCdBteV7C8air9rNcwPnyt71idq0X+yNi9pATzTb4D16ljM1fg=; path=/